RetractedArticleBioengineered2022

Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway.

Peng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.